Clinical Trial Update: Romidepsin Maintenance After Allogeneic Stem Cell Transplantation [Phase 1]

View source ↗

Summary

Phase 1 trial update on romidepsin as maintenance therapy after allogeneic stem cell transplantation. The study status is completed and includes patients with v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Peripheral T-cell Lymphoma
• T-large Granular Lymphocytic Leukemia
• T-lymphoblastic Leukemia Lymphoma
• T-prolymphocytic Leukemia

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia | Phase 1 | Status: COMPLETED